Endogenous nitric oxide attenuates neutrally mediated cutaneous vasoconstriction

Journal of Physiology

Volumn 585, Issue 2, 2007, Pages 627-634

  Shibasaki, Manabu ^a,b   Durand, Sylvain ^b   Davis, Scott L ^b,c   Cui, Jian ^b   Low, David A ^b   Keller, David M ^b,c   Crandall, Craig G ^b,c  

^a NARA WOMEN'S UNIVERSITY   (Japan)

^b PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BOTULINUM TOXIN A; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ADULT; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DERMIS; HUMAN; HUMAN EXPERIMENT; INDUCED HYPOTHERMIA; LOWER BODY NEGATIVE PRESSURE; MICRODIALYSIS; NEUROTRANSMITTER RELEASE; NORMAL HUMAN; ORTHOSTATIC STRESS; PRIORITY JOURNAL; PROTEIN NUCLEIC ACID INTERACTION; SKIN BLOOD FLOW; SKIN CONDUCTANCE; VASOCONSTRICTION; BLOOD VESSEL PARAMETERS; COOLING; CUTANEOUS VASCULAR CONDUCTANCE; FOREARM; HEATING; SKIN BLOOD VESSEL; STANDING;

ADENOSINE; ADULT; BODY TEMPERATURE REGULATION; BOTULINUM TOXIN TYPE A; ENZYME INHIBITORS; FEVER; HUMANS; HYPOTENSION; LOWER BODY NEGATIVE PRESSURE; MICRODIALYSIS; NEUROMUSCULAR AGENTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; SKIN; SKIN TEMPERATURE; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 36649012967     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.144030     Document Type: Article

References (26)

1. Bennett LA, Johnson JM, Stephens DP, Saad AR & Kellogg DL Jr (2003). Evidence for a role for vasoactive intestinal peptide in active vasodilatation in the cutaneous vasculature of humans. J Physiol 552, 223-232.
2. Chavoshan B, Sander M, Sybert TE, Hansen J, Victor RG & Thomas GD (2002). Nitric oxide-dependent modulation of sympathetic neural control of oxygenation in exercising human skeletal muscle. J Physiol 540, 377-386.
3. Costa F, Christensen NJ, Farley G & Biaggioni I (2001). NO modulates noradrenaline release in human skeletal muscle: Implications for neural preconditioning. Am J Physiol Regul Integr Comp Physiol 280, R1494-R1498.
4. Crandall CG, Johnson JM, Kosiba WA & Kellogg DL Jr (1996). Baroreceptor control of the cutaneous active vasodilator system. J Appl Physiol 81, 2192-2198.
5. Durand S, Davis SL, Cui J & Crandall CG (2005). Exogenous nitric oxide inhibits sympathetically mediated vasoconstriction in human skin. J Physiol 562, 629-634.
6. Greenberg SS, Diecke FP, Peevy K & Tanaka TP (1990). Release of noradrenaline from adrenergic nerve endings of blood vessels is modulated by endothelium-derived relaxing factor. Am J Hypertens 3, 211-218.
7. Habler HJ, Wasner G & Janig W (1997). Attenuation of neurogenic vasoconstriction by nitric oxide in hindlimb microvascular beds of the rat in vivo. Hypertension 30, 957-961.
8. Johnson JM, Niederberger M, Rowell LB, Eisman MM & Brengelmann GL (1973). Competition between cutaneous vasodilator and vasoconstrictor reflexes in man. J Appl Physiol 35, 798-803.
9. Johnson JM & Proppe DW (1996). Cardiovascular adjustments to heat stress. In Handbook of Physiology, section 4, Environmental Physiology, ed. Fregly MJ & Blatteis CM, pp. 215-243. Oxford University Press, New York, NY.
10. Kellogg DL Jr (2006). In vivo mechanisms of cutaneous vasodilatation and vasoconstriction in humans during thermoregulatory challenges. J Appl Physiol 100, 1709-1718.
11. Kellogg DL Jr, Crandall CG, Liu Y, Charkoudian N & Johnson JM (1998). Nitric oxide and cutaneous active vasodilatation during heat stress in humans. J Appl Physiol 85, 824-829.
12. Kellogg DL Jr, Johnson JM & Kosiba WA (1989). Selective abolition of adrenergic vasoconstrictor responses in skin by local iontophoresis of bretylium. Am J Physiol Heart Circ Physiol 257, H1599-H1606.
13. Kellogg DL Jr, Johnson JM & Kosiba WA (1990). Baroreflex control of the cutaneous active vasodilator system in humans. Circ Res 66, 1420-1426.
14. Kellogg DL Jr, Pergola PE, Piest KL, Kosiba WA, Crandall CG, Grossmann M & Johnson JM (1995). Cutaneous active vasodilatation in humans is mediated by cholinergic nerve cotransmission. Circ Res 77, 1222-1228.
15. Kolo LL, Westfall TC & Macarthur H (2004). Nitric oxide decreases the biological activity of noradrenaline resulting in altered vascular tone in the rat mesenteric arterial bed. Am J Physiol Heart Circ Physiol 286, H296-H303.
16. Lind AR, Leithead CS & McNicol GW (1968). Cardiovascular changes during syncope induced by tilting men in the heat. J Appl Physiol 25, 268-276.
17. Rowell LB (1986). Human Circulation Regulation During Physical Stress. Oxford University Press, New York.
18. Rowell LB, Brengelmann GL & Murray JA (1969). Cardiovascular responses to sustained high skin temperature in resting man. J Appl Physiol 27, 673-680.
19. Shastry S, Dietz NM, Halliwill JR, Reed AS & Joyner MJ (1998). Effects of nitric oxide synthase inhibition on cutaneous vasodilatation during body heating in humans. J Appl Physiol 85, 830-834.
20. Shastry S, Minson CT, Wilson SA, Dietz NM & Joyner MJ (2000). Effects of atropine and L-NAME on cutaneous blood flow during body heating in humans. J Appl Physiol 88, 467-472.
21. Shibasaki M, Davis SL, Cui J, Low DA, Keller DM, Durand S & Crandall CG (2006). Neurally mediated vasoconstriction is capable of decreasing skin blood flow during orthostasis in the heat-stressed human. J Physiol 575, 953-959.
22. Shibasaki M, Wilson TE, Cui J & Crandall CG (2002). Acetylcholine released from cholinergic nerves contributes to cutaneous vasodilatation during heat stress. J Appl Physiol 93, 1947-1951.
23. Taylor WF, Johnson JM, Kosiba WA & Kwan CM (1989). Cutaneous vascular responses to isometric handgrip exercise. J Appl Physiol 66, 1586-1592.
24. Vanhoutte PM, Verbeuren TJ & Webb RC (1981). Local modulation of adrenergic neuroeffector interation in the blood vessel wall. Physiol Rev 61, 151-247.
25. 2 histamine receptors in cutaneous thermal hyperemia to local heating in humans. J Appl Physiol 100, 535-540.
26. Zanzinger J, Czachurski J & Seller H (1994). Inhibition of sympathetic vasoconstriction is a major principle of vasodilatation by nitric oxide in vivo. Circ Res 75, 1073-1077.